Cargando…
Should We Consider Screening Spirometry in Individuals Who Are “Asymptomatic”?
Autor principal: | Fortis, Spyridon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353965/ https://www.ncbi.nlm.nih.gov/pubmed/35913464 http://dx.doi.org/10.1513/AnnalsATS.202205-374ED |
Ejemplares similares
-
The golden era of videolaryngoscopy: costs we should consider
por: Choi, Geun Joo
Publicado: (2022) -
Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017) -
Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients and the Risk of Hypercoagulability: Should we Consider Routine Screening?
por: Ezzat, Haitham, et al.
Publicado: (2023) -
How Should We Consider New Theories of Chiari Malformation Pathogenesis?
por: Chou, Dean
Publicado: (2019) -
How Should Very Severe Aortic Stenosis Be Defined in Asymptomatic Individuals?
por: Tribouilloy, Christophe, et al.
Publicado: (2019)